Evidence map›Paper›PMID 23316296›Full record

Trial reportJournal of the American Heart Association2012

Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus.

Graham S Hillis, Jun Hata, Mark Woodward, Vlado Perkovic, Hisatomi Arima, Clara K Chow, Sophia Zoungas, Anushka Patel, Neil R Poulter, Giuseppe Mancia and 2 more

Registry-linked trialOpen access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Heart Association, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00145925 (ADVANCE - Action in Diabetes and Vascular Disease), which is not on this map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00145925 phase3completednot on this map

ADVANCE - Action in Diabetes and Vascular Disease: Preterax and Diamicron - MR Controlled Evaluation

TypeinterventionalSponsorThe George InstituteRan2001 to 2008Enrolled11,140ConditionsDiabetes Mellitus, Type 2ArmsPerindopril-indapamide, Gliclazide MR-based glucose lowering
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 66 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Graham S HillisThe George Institute for Global Health, University of Sydney, Australia. ghillis@georgeinstitute.org.au
Jun Hata
Mark Woodward
Vlado Perkovic
Hisatomi Arima
Clara K Chow
Sophia Zoungas
Anushka Patel
Neil R Poulter
Giuseppe Mancia
Bryan Williams
John Chalmers
The George Institute for Global Health · AUUniversity of Sydney · AUImperial College London · GBUniversity College London · GBUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA higher resting heart rate is associated with an increased probability of cardiovascular complications and premature death in patients with type 2 diabetes mellitus. The impact of heart rate on the risk of developing microvascular complications, such as diabetic retinopathy and nephropathy, is, however, unknown. The present study tests the hypothesis that a higher resting heart rate is associated with an increased incidence and a greater progression of microvascular complications in patients with type 2 diabetes mellitus. METHODS AND

resultsThe relation between baseline resting heart rate and the development of a major microvascular event was examined in 11 140 patients who participated in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) study. Major microvascular events were defined as a composite of new or worsening nephropathy or new or worsening retinopathy. Patients with a higher baseline heart rate were at increased risk of a new major microvascular complication during follow-up (adjusted hazard ratio: 1.13 per 10 beats per minute; 95% confidence interval: 1.07-1.20; P<0.001). The excess hazard was evident for both nephropathy (adjusted hazard ratio: 1.16 per 10 beats per minute; 95% confidence interval: 1.08-1.25) and retinopathy (adjusted hazard ratio: 1.11 per 10 beats per minute; 95% confidence interval: 1.02-1.21).

conclusionPatients with type 2 diabetes mellitus who have a higher resting heart rate experience a greater incidence of new-onset or progressive nephropathy and retinopathy. CLINICAL

trial registrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT00145925. http://www.advance-trial.com/static/html/prehome/prehome.asp.

Indexed as

AgedDiabetes ComplicationsDiabetes Mellitus, Type 2Diabetic AngiopathiesFemaleFollow-Up StudiesHeart RateHumansIncidenceMaleMicrocirculationMiddle AgedRiskTachycardiadiabetes mellitus, type 2heart ratemicrocirculation

Identifiers

PMID23316296
PMCPMC3541618
OpenAlexW2111983625

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.